Gilead Sciences Closes Durham, North Carolina R&D Office
06/24/2010
"This comes after a lengthy review," Flood said. "We will be consolidating our R&D activities in our Foster City, [California] headquarters."
The Durham closure leaves Gilead with no presence in North Carolina.
Gilead is a bioscience company that conducts anti-viral research and development. The Durham office conducted hepatitis B and C clinical research.
Project Announcements
Swiss-Based Stadler Expands Salt Lake City, Utah, Operations
09/15/2025
South Korea-Based PPI America Plans Iron County, Utah, Manufacturing Operations
09/15/2025
Apozeal Pharmaceuticals Expands Bucks County, Pennsylvania, Drug Manufacturing Operations
09/14/2025
Georgia-Pacific Expands Monroe County, Alabama, Cellulose Mill Operations
09/14/2025
Noble Plastics Expands St. Landry Parish, Louisiana, Production Operations
09/14/2025
Systems Planning & Analysis Expands Alexandria-Fairfax County, Virginia, Operations
09/13/2025
Most Read
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
What We’re Getting Wrong About Gen Z’s Future in the Skilled Trades
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
A New Course for U.S. Shipbuilding
Q3 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025